CBD, Linalool & Stress: What Human Research Shows for Busy Professionals and Runners

CBD and linalool are widely discussed in conversations about stress, relaxation, and recovery. But when the question becomes more specific—work stress, marathon training, endurance performance, or faster recovery—the human evidence is much more limited than the marketing language often suggests.

The most defensible conclusion today is straightforward: CBD has been studied in several human stress and exercise models, with mixed results. Linalool has limited human experimental evidence, but it has not been established as a treatment for workplace stress. And controlled research in trained runners has not shown that CBD improves endurance performance.

Why work stress and marathon training overlap

Professionals training for long-distance events are often managing two forms of load at the same time: occupational demands and physical training. Sleep, perceived stress, recovery time, nutrition, training volume, and mental fatigue can all influence how a person feels during a training block.

That makes cannabinoids and terpenes attractive subjects for research, but it also creates a common mistake: evidence about one outcome is often stretched into claims about another. A compound studied for anxiety during public speaking is not automatically proven to improve workplace performance. A compound studied during a treadmill protocol is not automatically proven to improve marathon times.

What is CBD?

Cannabidiol, or CBD, is a naturally occurring cannabinoid found in hemp and cannabis. Unlike THC, CBD is not generally associated with intoxication. Researchers have studied it across a wide range of areas, including anxiety-related outcomes, sleep, pain, exercise, and neurological conditions.

For consumers, the important distinction is between being studied and being proven effective. Human CBD research varies widely in dose, formulation, population, duration, and study design. Results from purified CBD at hundreds of milligrams should not be treated as proof that a lower-dose retail tincture will produce the same outcome.

Does CBD reduce stress?

A public-speaking model found a dose-specific effect

In a randomized double-blind study of 57 healthy men, researchers tested 150 mg, 300 mg, and 600 mg of oral CBD before a simulated public-speaking task. The 300 mg group showed a statistically significant reduction in anxiety during the speech compared with placebo, while the 150 mg and 600 mg groups did not show the same effect.

This study is useful because it demonstrates how CBD effects may depend on dose and context. It does not establish a general consumer dose for workplace stress.

Review the public-speaking CBD study on PubMed.

A workplace-related clinical trial reported benefit—but with important limitations

A 2021 randomized clinical trial studied 120 frontline health care professionals during the COVID-19 pandemic. The treatment group received 300 mg of CBD daily plus standard care for 28 days. Researchers reported lower emotional-exhaustion scores in the CBD group at several time points.

However, the study was open-label rather than double-blind and placebo-controlled. Five participants in the CBD group experienced serious adverse events, including elevated liver enzymes and a severe skin reaction. The authors specifically called for future double-blind placebo-controlled research.

Review the health care worker trial on PubMed.

A separate trial found no reduction in worry

A 2023 double-blind randomized placebo-controlled study enrolled 63 people with elevated trait worry and compared 50 mg CBD, 300 mg CBD, and placebo. Neither acute nor repeated CBD significantly reduced worry severity. Repeated 300 mg CBD did improve some anxiety symptoms, but the study did not support a broad claim that CBD reduces cognitive worry.

Review the CBD worry study on PubMed.

Bottom line: individual human studies have reported changes in selected stress- or anxiety-related measures, but the results are not consistent enough to claim that CBD is an established treatment for workplace stress, anxiety, or burnout.

What is linalool?

Linalool is an aromatic terpene found in many plants and essential oils. It is commonly associated with floral or lavender-like aromas and can also appear in hemp and cannabis terpene profiles.

Golden Gardens uses terpene education to help consumers understand aroma and chemistry. That is different from claiming that a terpene produces a clinically proven psychological effect. You can explore our dedicated linalool terpene guide for more background on this compound.

What does human research show about linalool and stress?

Human linalool evidence is limited. A 2005 study in 24 healthy volunteers examined jasmine tea odor and R-(-)-linalool, measuring autonomic activity and mood. Researchers observed short-term physiological and mood-related changes, but the study was small and does not establish linalool as a treatment for stress.

Review the 2005 linalool study on PubMed.

A more recent 2024 experiment randomly assigned 48 participants to inhaled linalool, beta-caryophyllene, citral, or an odorless control before stressful cognitive tasks. Different compounds produced different physiological responses. The clearest reductions in anxiety scores were reported for beta-caryophyllene and citral, not linalool.

Review the 2024 terpene inhalation study on PubMed.

This distinction matters. Lavender research, aromatherapy research, and research on isolated linalool are not interchangeable. A whole botanical extract may contain multiple active compounds, and an inhaled terpene experiment cannot automatically be used to substantiate an oral tincture claim.

Have CBD and linalool been proven to work better together?

We did not identify convincing controlled human evidence showing that a finished CBD-plus-linalool consumer product reduces workplace stress, improves marathon training, or enhances endurance performance.

That means the popular idea of cannabinoid-terpene “synergy” should be treated as a research hypothesis unless the exact combination, dose, route, and outcome have been studied in humans.

For a broader explanation of how cannabinoids and terpenes differ, see Cannabinoids and Terpenes Explained.

CBD and marathon training: what the runner studies show

Randomized endurance trial in trained runners

A randomized, double-blind, placebo-controlled crossover study in 25 trained runners compared placebo with 50 mg and 300 mg CBD before exercise. Participants completed a 60-minute treadmill run followed by an incremental run to exhaustion.

Neither CBD dose significantly improved perceived exertion, enjoyment, mood, anxiety, pain, or endurance-related outcomes in the protocol.

Review the trained-runner CBD study on PubMed.

A small two-mile pilot found subjective changes but no faster performance

A pilot crossover study published in late 2025 tested 300 mg CBD in 12 runners before a two-mile treadmill time trial. The CBD condition was associated with greater feelings of calm and relaxation and a lower rating of perceived exertion at mile one.

However, there was no statistically significant improvement in run time. The sample was very small, and the findings should be viewed as exploratory.

Review the two-mile CBD pilot on PubMed.

Bottom line for runners: CBD is being investigated in exercise settings, but controlled human research has not established it as an endurance-performance enhancer.

What marathon runners should focus on first

For athletes balancing work and training, the strongest performance foundations remain the familiar ones: appropriate training progression, sleep, nutrition, hydration, injury management, and recovery time. Cannabinoid products should not be positioned as substitutes for those fundamentals.

Research interest in CBD may continue to grow, but Golden Gardens does not treat emerging evidence as permission to promise better race times, lower cortisol, faster recovery, or protection from overtraining.

Drug testing and competitive athletes

Competitive athletes should treat cannabinoid products as a separate compliance issue from general wellness use. World Anti-Doping Agency rules distinguish cannabidiol from other cannabinoids, but contamination and the presence of other cannabinoids can still create testing risk.

Anyone subject to anti-doping rules should review the current prohibited list and their governing body's guidance before using cannabinoid products.

Check the current WADA Prohibited List.

How to evaluate a CBD or terpene product

A Certificate of Analysis, or COA, can help verify what a laboratory measured in a specific batch. Depending on the report, this may include cannabinoid potency, terpene content, and contaminant testing.

A COA can help answer questions such as:

• How much CBD was measured in the tested batch?
• Were THC or other cannabinoids detected?
• Was linalool actually quantified in a terpene panel?
• Does the batch number match the product being sold?
• Which contaminant panels were performed?

A COA cannot prove that a product reduces stress, improves sleep, increases endurance, or speeds recovery. Laboratory chemistry and clinical efficacy are different forms of evidence.

View Golden Gardens Certificates of Analysis.

Golden Gardens formulation examples

For consumers comparing cannabinoid formats, Golden Gardens offers multiple tincture formulations, including DRIFT Zero THC and DRIFT with THC. These products can be evaluated by their ingredient panels, cannabinoid content, format, and batch testing rather than by assuming that research on isolated CBD or linalool predicts the effect of the finished product.

Consumers exploring topical formats can also review Canna-Bliss Hemp Recovery Balm. Topicals should be evaluated separately from oral CBD because route of administration matters.

CBD safety deserves attention too

The FDA has identified potential CBD safety concerns, including liver injury and drug interactions. That is especially relevant for consumers taking prescription medications or using high-dose CBD products.

Read the FDA's CBD consumer information.

Frequently asked questions

Does CBD help with workplace stress?

Some human studies have reported changes in selected stress- and anxiety-related outcomes, but the overall evidence is mixed. CBD is not established as a treatment for routine workplace stress.

Does CBD lower cortisol?

The current evidence does not justify a general claim that consumer CBD products reliably lower cortisol.

What is linalool?

Linalool is an aromatic terpene found in many plants and essential oils and in some hemp and cannabis terpene profiles.

Does linalool reduce anxiety?

Human research is limited and mixed. Existing studies are not sufficient to establish linalool as an anxiety treatment.

Do CBD and linalool work better together?

There is not enough controlled human evidence to establish that a CBD-plus-linalool combination is more effective for stress, exercise, or recovery than either compound alone.

Does CBD improve marathon performance?

Controlled studies in runners have not demonstrated an improvement in endurance performance.

Does CBD help athletes recover faster?

Research is ongoing, but current evidence does not establish a consistent recovery benefit from consumer CBD products.

What can a CBD COA prove?

A COA can verify tested chemistry and safety panels for a specific batch. It does not prove a health or performance benefit.

Is THC-free CBD automatically safe for drug-tested athletes?

No. Product labeling alone cannot eliminate contamination or anti-doping risk. Athletes should review current governing-body rules and batch testing.

The bottom line

CBD and linalool are legitimate research subjects, but the evidence should be described at the level it actually exists. CBD has mixed human findings in stress-related research and has not demonstrated a clear endurance-performance benefit in trained runners. Linalool has limited human experimental evidence and has not been established as a treatment for workplace stress.

Golden Gardens' approach is to separate ingredient chemistry from clinical claims: understand the cannabinoid and terpene profile, verify the current batch with a COA, and avoid turning early research into a promise.

Explore the science: Learn about linalool · Explore cannabinoids and terpenes · Review COAs

This article is for educational purposes and is not medical advice. Golden Gardens products are not intended to diagnose, treat, cure, or prevent disease. Consult a qualified health professional before using CBD if you take medications, have a medical condition, are pregnant or breastfeeding, or participate in drug-tested sport.

References

• Linares IM et al. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test. Braz J Psychiatry.
• Crippa JAS et al. Cannabidiol plus standard care versus standard care alone for emotional exhaustion among frontline health care workers. JAMA Network Open. 2021.
• Gournay LR et al. Effects of cannabidiol on worry and anxiety among high trait worriers. Psychopharmacology. 2023.
• Pei S et al. Physiological response differences of beta-caryophyllene, linalool and citral inhalation. Heliyon. 2024.
• Crossland BW et al. Acute effects of cannabidiol on physiological and subjective responses to endurance exercise. 2025.
• Bell ER et al. Acute cannabidiol and two-mile time trial performance: a pilot study. Published 2025.
• U.S. Food and Drug Administration. Consumer information on cannabis-derived compounds including CBD.
• Federal Trade Commission. Health Products Compliance Guidance.